PROPHYLACTIC ANTIBIOTICS IN BILIARY AND LIVER SURGERY

被引:2
作者
CHALFINE, A
机构
[1] Hôpital Saint-Joseph, Paris
来源
ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION | 1994年 / 13卷 / 05期
关键词
D O I
10.1016/S0750-7658(05)81789-7
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Today, hepatic and biliary surgery includes conventional biliary surgery, laparoscopic surgery, interventional radiology, endoscopy and hepatic resection surgery. In conventional biliary surgery, the benefit of antibiotic prophylaxis has been demonstrated. Among the risk factors, some are specific (age > 65 years, gallstones in the common bile duct with or without jaundice, history of acute cholecystitis or of biliary surgery) and the others are non specific such as the CDC new index risk (for scoring from 0 to 3, wound infection rates are respectively 1.36, 2.01, 7.11, 11.54%). The targets for antibiotics used in conventional biliary surgery are E. coli, Klebsiella and Streptococcus. In biliary laparoscopic surgery, the rate of infectious complications and results of antibiotic prophylaxis have not been assessed. However, in laparoscopic surgery, the use of an antibiotic prophylaxis similar to that employed in conventional biliary surgery seems logical. In interventional radiology and endoscopy, the modalities and the benefit of antibiotic prophylaxis have not yet been assessed. Infections (angiocholecystitis) secondary to these procedures are frequent and severe. They are due to multiresistant hospital microorganisms. Antibiotic prophylaxis regimens for hepatic resections have not yet been assessed and are the same as for conventional biliary surgery.
引用
收藏
页码:S138 / S144
页数:7
相关论文
共 48 条
[1]  
Altemeier, Culberton, Vetto, Prophylactic antibiotic therapy, Arch Surg, 71, pp. 2-6, (1955)
[2]  
Anderson, Saarela, Tranberg, Bengmark, Intraabdominal abcess formation after major liver resection, Acta Chir Scand, 156, pp. 707-710, (1990)
[3]  
Audisio, Bozzetti, Severini, Bellegotti, Bellomi, Cozzi, Pisani, Callegari, Doci, Gennari, The occurence of cholangitis after percutaneous biliary drainage : evaluation of some risk factors, Surgery, 103, pp. 507-512, (1988)
[4]  
Bergeron, Mendelson, Harding, Mandell, Fong, Rachlis, Chan, Biron, Feld, Segal, Cefoperazone compared with ampicillin plus tobramycin for severe biliary tract infection, Antimicrob Agents Chemother, 32, 8, pp. 1231-1236, (1988)
[5]  
Berne, Yellin, Appleman, Gill, Chenella, Heseltine, Controlled comparison of cefmetazole with cefoxitin for prophylaxis in elective cholecystectomy, Surg Gynecol Obstet, 170, 2, pp. 137-140, (1990)
[6]  
Brogard, Dorner, Blickle, Jehl, Monteil, Biliary elimination and hepatic disposition of piperacillin : an experimental evaluation, Path Biol, 38, 5 bis, pp. 495-499, (1990)
[7]  
Brogard, Jehl, Blickle, Arnaud, Monteil, Place des métabolites de la eiprofloxacine dans son élimination biliaire et urinaire chez l'homme, Path Biol, 36, 5 bis, pp. 719-723, (1988)
[8]  
Burke, The effective period of preventive antibiotic action in experimental incisions and dermal lesions, Surgery, 50, pp. 161-168, (1961)
[9]  
Cann, Watkins, George, Payne-James, Crawfurd, Rogers, A trial of mezlocillin versus cefuroxime with or without metronidazole for the prevention of wound sepsis after biliary and gastrointestinal surgery, Journal of Hospital Infection, 12, pp. 207-214, (1988)
[10]  
Carlet, Bleriot, Chalfine, Dazza, Goldstein, Les céphalosporines dans le traitement des infections intra-abdominales : place de la ceftriaxone, Méd Mal Infect, 19, pp. 72-77, (1989)